CASP9 and lung cancer: Kang et al. [70] determined that ATL III reduces the viability of human lung cancer A549 cells, increases LDH release, induces apoptosis, and has anti-lung cancer effects, possibly by increasing Caspase-3 and Caspase-9 protein expression, activating the mitochondrial pathway, leading to PAPR cleavage.